AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 20, 2026

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
May 20, 2026

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

Indeterminate GlobeNewswire
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Indeterminate GlobeNewswire
XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale
May 20, 2026

XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale

Indeterminate GlobeNewswire
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
May 20, 2026

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Indeterminate GlobeNewswire
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
May 20, 2026

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
May 20, 2026

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

Indeterminate GlobeNewswire
Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine
May 20, 2026

Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine

Indeterminate GlobeNewswire
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
May 20, 2026

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
May 20, 2026

Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform

Indeterminate GlobeNewswire
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
May 20, 2026

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

Indeterminate GlobeNewswire
Emergent BioSolutions to Participate in Upcoming Investor Conferences
May 20, 2026

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Medline Inc. announces launch of secondary offering of Class A common stock
May 20, 2026

Medline Inc. announces launch of secondary offering of Class A common stock

Indeterminate GlobeNewswire
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026

4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial

Indeterminate GlobeNewswire
Final Results and Notice of AGM
May 20, 2026

Final Results and Notice of AGM

Indeterminate GlobeNewswire
Syndax Announces Participation in Upcoming Investor Conferences
May 20, 2026

Syndax Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026
May 20, 2026

Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
May 20, 2026

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting
May 20, 2026

NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting

Indeterminate GlobeNewswire
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
May 20, 2026

Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors

Indeterminate GlobeNewswire
C4 Therapeutics to Participate in Upcoming Conferences
May 20, 2026

C4 Therapeutics to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.